315 related articles for article (PubMed ID: 11108768)
1. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
Lapchak PA; Chapman DF; Zivin JA
Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Lapchak PA; Chapman DF; Zivin JA
Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
[TBL] [Abstract][Full Text] [Related]
3. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
[TBL] [Abstract][Full Text] [Related]
4. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
Lapchak PA; Araujo DM; Song D; Zivin JA
Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
[TBL] [Abstract][Full Text] [Related]
5. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Sumii T; Lo EH
Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
[TBL] [Abstract][Full Text] [Related]
6. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
Lapchak PA; Zivin JA
Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
[TBL] [Abstract][Full Text] [Related]
8. Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model.
Chapman DF; Lyden P; Lapchak PA; Nunez S; Thibodeaux H; Zivin J
Stroke; 2001 Mar; 32(3):748-52. PubMed ID: 11239197
[TBL] [Abstract][Full Text] [Related]
9. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin reduces thrombolytic-induced intracerebral hemorrhage in embolized rabbits.
Lapchak PA; Han MK
Brain Res; 2009 Dec; 1303():144-50. PubMed ID: 19781532
[TBL] [Abstract][Full Text] [Related]
10. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
11. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits.
Lapchak PA; Araujo DM; Pakola S; Song D; Wei J; Zivin JA
Stroke; 2002 Sep; 33(9):2279-84. PubMed ID: 12215599
[TBL] [Abstract][Full Text] [Related]
12. Extension of the thrombolytic time window with minocycline in experimental stroke.
Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
[TBL] [Abstract][Full Text] [Related]
13. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence.
Lapchak PA; Song D; Wei J; Zivin JA
Exp Neurol; 2004 Aug; 188(2):286-91. PubMed ID: 15246828
[TBL] [Abstract][Full Text] [Related]
15. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
16. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I
Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores.
Lapchak PA; Song D; Wei J; Zivin JA
Exp Neurol; 2004 Aug; 188(2):279-85. PubMed ID: 15246827
[TBL] [Abstract][Full Text] [Related]
19. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
[TBL] [Abstract][Full Text] [Related]
20. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
